PNC FINANCIAL SERVICES GROUP, INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,600
+18.4%
1,001
+170.5%
0.00%
Q2 2023$17,397
+14.2%
370
+1.9%
0.00%
Q1 2023$15,232
+10.0%
3630.0%0.00%
Q4 2022$13,846
-1.1%
3630.0%0.00%
Q3 2022$14,000
+16.7%
363
-4.0%
0.00%
Q2 2022$12,000
-45.5%
378
-45.1%
0.00%
Q1 2022$22,000
-38.9%
688
-17.8%
0.00%
Q4 2021$36,000
+5.9%
837
+11.6%
0.00%
Q3 2021$34,000
-44.3%
750
-29.1%
0.00%
Q2 2021$61,000
-23.8%
1,058
-1.0%
0.00%
Q1 2021$80,000
+8.1%
1,069
+24.6%
0.00%
Q4 2020$74,000
+48.0%
858
+6.1%
0.00%
Q3 2020$50,000
+56.2%
809
+7.6%
0.00%
Q2 2020$32,000
+52.4%
752
+0.3%
0.00%
Q1 2020$21,000
-12.5%
750
+123.9%
0.00%
Q4 2019$24,000
-75.5%
335
-51.9%
0.00%
Q3 2019$98,000
+25.6%
696
+61.9%
0.00%
Q2 2019$78,000
-11.4%
430
-21.1%
0.00%
Q1 2019$88,000
+1660.0%
545
+1138.6%
0.00%
Q4 2018$5,000
-44.4%
44
-30.2%
0.00%
Q3 2018$9,000
+50.0%
63
+65.8%
0.00%
Q2 2018$6,000
+50.0%
38
+58.3%
0.00%
Q1 2018$4,000
+100.0%
24
+140.0%
0.00%
Q4 2017$2,0000.0%10
-86.7%
0.00%
Q2 2016$2,000
-33.3%
75
-3.8%
0.00%
Q1 2016$3,000
-72.7%
78
-58.7%
0.00%
Q4 2015$11,000
+57.1%
189
+5.0%
0.00%
Q3 2015$7,000
-56.2%
180
-19.3%
0.00%
Q2 2015$16,000
+77.8%
223
+31.2%
0.00%
Q1 2015$9,0001700.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders